Maze Therapeutics, Inc. Common Stock (MAZE) financials · $525.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Maze Therapeutics, Inc. Common Stock (MAZE) $525.3M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | $167.5M |
| Operating Income | -$142.9M | $57.6M |
| Net Income | -$131.1M | $52.2M |
| EPS (Diluted) | -$3.05 | $1.25 |
| Line | FY2025 |
|---|---|
| Total Assets | $397.1M |
| Current Assets | $349.7M |
| Cash & Equivalents | $189.2M |
| PP&E | $5.04M |
| Total Liabilities | $42.2M |
| Current Liabilities | $22.6M |
| Shareholders' Equity | $355.0M |
| Retained Earnings | -$489.5M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$111.9M | $76.0M |
| CapEx | $794.0K | $1.15M |
| Investing Cash Flow | -$171.0M | -$1.15M |
| Financing Cash Flow | $275.3M | $92.8M |
| Free Cash Flow | -$112.7M | $74.8M |
FAQ
What is MAZE P/E and revenue?
Maze Therapeutics, Inc. Common Stock (MAZE) $525.3M cap.
What is MAZE revenue?
MAZE income-statement cache has no revenue figure yet.
Is MAZE profitable?
Maze Therapeutics, Inc. Common Stock last cached net income is -$131.1M (FY2025).
What are MAZE total assets?
Maze Therapeutics, Inc. Common Stock last cached total assets are $397.1M (FY2025).
What is MAZE free cash flow?
Maze Therapeutics, Inc. Common Stock last cached free cash flow is -$112.7M (FY2025).
Not investment advice. Cached statements, not a live tape.